» Articles » PMID: 30696519

Ketamine Tolerance in Sprague-Dawley Rats After Chronic Administration of Ketamine, Morphine, or Cocaine

Overview
Journal Comp Med
Specialty General Medicine
Date 2019 Jan 31
PMID 30696519
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Ketamine is one of the most commonly used anesthetics in human and veterinary medicine, but its clinical effectiveness is often compromised due to tolerance to its anesthetic effects. Although ketamine tolerance has been demonstrated in a number of behavioral measures, no published work has investigated tolerance to ketamine's anesthetic effects other than duration of anesthesia. In addition, a reported practice in anesthesiology is to alter anesthetic doses for procedures when the patient has a history of drug abuse. Empirically investigating the effects of administration of a drug of abuse on ketamine's potency and efficacy to produce anesthesia could help in the creation of anesthetic plans that maximize safety for both clinicians and patients. The goal of the current study was to test the effects of repeated administration of ketamine, morphine, or cocaine on ketamine's ability to produce anesthesia. In 2 studies, male Sprague-Dawley rats received daily injections of ketamine (32 or 100 mg/kg IP), morphine (3.2 or 5.6 mg/kg IP), or cocaine (3.2 or 10 mg/kg IP) for 14 consecutive days and then were tested on day 15 for ketamine-induced anesthesia by using a cumulative-dosing procedure (32 to 320 mg/kg IP). Chronic treatment with either ketamine or morphine-but not cocaine-produced tolerance to ketamine's anesthetic effects in a dose-dependent manner. These results suggest that ketamine's clinical effectiveness as an anesthetic will vary as a function of its history of use. Furthermore, given that chronic morphine administration produced tolerance to ketamine's anesthetic effects, various pain medications may reduce ketamine's effectiveness for anesthesia.

Citing Articles

A 13-week subchronic toxicity study of linalool oxide in Crl:CD(SD) rats.

Uneyama M, Toyoda T, Doi Y, Matsushita K, Akane H, Morikawa T J Toxicol Pathol. 2024; 37(4):151-161.

PMID: 39359898 PMC: 11442264. DOI: 10.1293/tox.2024-0012.


Ischemia reperfusion myocardium injuries in type 2 diabetic rats: Effects of ketamine and insulin on LC3-II and mTOR expression.

Tao Z, Lin R, Zhang R, He P, Lei C, Li Y Int J Immunopathol Pharmacol. 2023; 37:3946320231196450.

PMID: 37643354 PMC: 10467302. DOI: 10.1177/03946320231196450.


Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review.

Tsang V, Tao B, Dames S, Walsh Z, Kryskow P Ther Adv Psychopharmacol. 2023; 13:20451253231171512.

PMID: 37256163 PMC: 10225955. DOI: 10.1177/20451253231171512.


Pronounced Regional Variation in Esketamine and Ketamine Prescribing to US Medicaid Patients.

Aguilar A, Beauregard B, Conroy C, Khatiwoda Y, Horsford S, Nichols S J Psychoactive Drugs. 2023; 56(1):33-39.

PMID: 36857284 PMC: 10471778. DOI: 10.1080/02791072.2023.2178558.


Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions.

Vines L, Sotelo D, Johnson A, Dennis E, Manza P, Volkow N Intell Med. 2022; 2(2):61-68.

PMID: 35783539 PMC: 9249268. DOI: 10.1016/j.imed.2022.03.001.


References
1.
Byer D, GOULD Jr A . Development of tolerance to ketamine in an infant undergoing repeated anesthesia. Anesthesiology. 1981; 54(3):255-6. DOI: 10.1097/00000542-198103000-00016. View

2.
Cumming J . The development of an acute tolerance to ketamine. Anesth Analg. 1976; 55(6):788-91. DOI: 10.1213/00000539-197611000-00008. View

3.
Albrecht M, Henke J, Tacke S, Markert M, Guth B . Influence of repeated anaesthesia on physiological parameters in male Wistar rats: a telemetric study about isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl. BMC Vet Res. 2015; 10:310. PMC: 4301083. DOI: 10.1186/s12917-014-0310-8. View

4.
Rao J, Liu Z, Zhao C, Wei R, Zhao W, Tian P . Ketamine changes the local resting-state functional properties of anesthetized-monkey brain. Magn Reson Imaging. 2017; 43:144-150. DOI: 10.1016/j.mri.2017.07.025. View

5.
Zhang G, Liu W, Qiu L, Guo J, Wang X, Sun H . Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effects. Eur Psychiatry. 2015; 30(4):504-10. DOI: 10.1016/j.eurpsy.2014.11.007. View